411/420 | Cannabis Drug Scheduling | CashCropToday
0 Shares 2181 Views

411/420 | Cannabis Drug Scheduling

February 13, 2018
2181 Views

411/420 Host Joya Mia Italiano discusses drug scheduling and the uproar of Cannabis being classed with harder “drugs”. Get “The Downlow on the Business of Getting High” by tuning into 411/420

Tune In To New Episodes of 411/420 Thursdays, Exclusively on Cashcroptoday.com

CashCropToday Media is a global media, branding and technology company, with a focus on news and information about investing, technology, entrepreneurship, and the lifestyle of Cannabis & Hemp.
Reaching more than 1.2 million people worldwide, CashCropToday offers news coverage focused on Investing in Cannabis & Hemp through public traded companies, political opinions, and documentary programming, 7 days a week.

Connect with CashCropToday
Find us on Facebook: https://www.facebook.com/cashcroptoday
Follow us on Twitter: https://twitter.com/cashcroptoday
Follow us on Instagram: https://www.instagram.com/cashcroptoday

You may be interested

Featured CCT Interview with CEO of Eden Labs AC Braddock
Manufacturing
22 views
Manufacturing
22 views

Featured CCT Interview with CEO of Eden Labs AC Braddock

Editor - August 20, 2018

Eden Labs LLC. has been developing and providing plant based extraction equipment out of Seattle, Washington for some of the largest and most respected companies involved in…

VividGro, a Pegasus Capital Advisors Portfolio Company,  Announces Partnership with Merida Capital Partners
Market Watch
243 views
Market Watch
243 views

VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital Partners

Editor - August 17, 2018

Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million
Market Watch
335 views
Market Watch
335 views

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million

Editor - August 15, 2018

Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: